Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Curis Lifescien.
Quarter-by-quarter operating performance
Financials of Curis Lifescien.
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| Sales + | 23.70 | 35.21 | 35.13 | 49.13 | 62.27 |
| Expenses + | 20.12 | 31.95 | 26.74 | 39.59 | 49.35 |
| Operating Profit | 3.58 | 3.26 | 8.39 | 9.54 | 12.92 |
| OPM % | 15.11% | 9.26% | 23.88% | 19.42% | 20.75% |
| Other Income + | 0.02 | 0.34 | 0.31 | 0.51 | 0.05 |
| Interest | 1.62 | 1.33 | 0.85 | 1.11 | 1.04 |
| Depreciation | 0.75 | 0.73 | 0.68 | 0.67 | 0.68 |
| Profit before tax | 1.23 | 1.54 | 7.17 | 8.27 | 11.25 |
| Tax % | 59.35% | 20.13% | 32.22% | 26.24% | |
| Net Profit + | 0.49 | 1.23 | 4.87 | 6.11 | 8.21 |
| EPS in Rs | 9.80 | 24.60 | 97.40 | 10.30 | 13.83 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
Financials of Curis Lifescien.
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.50 | 0.50 | 0.50 | 5.93 | 5.93 |
| Reserves | -1.40 | -0.18 | 5.37 | 10.29 | 14.49 |
| Borrowings + | 17.62 | 16.19 | 17.09 | 15.61 | 14.81 |
| Other Liabilities + | 10.68 | 13.16 | 10.91 | 10.70 | 14.16 |
| Total Liabilities | 27.40 | 29.67 | 33.87 | 42.53 | 49.39 |
| Fixed Assets + | 12.33 | 12.20 | 11.59 | 10.99 | 10.78 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets + | 15.06 | 17.46 | 22.27 | 31.51 | 38.58 |
| Total Assets | 27.40 | 29.67 | 33.87 | 42.53 | 49.39 |
Financials of Curis Lifescien.
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 4.95 | 3.35 | 0.28 | -1.76 |
| Cash from Investing Activity + | -0.37 | -0.55 | -0.06 | -0.02 |
| Cash from Financing Activity + | -4.58 | -2.76 | 0.05 | 1.67 |
| Net Cash Flow | -0.01 | 0.04 | 0.27 | -0.11 |
| Free Cash Flow | 4.56 | 2.77 | 0.21 | -1.85 |
| CFO/OP | 138% | 103% | 3% | -2% |
Financials of Curis Lifescien.
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 96.10 | 98.17 | 104.94 | 55.87 |
| Inventory Days | 208.46 | 114.92 | 273.22 | 347.26 |
| Days Payable | 359.58 | 262.67 | 210.40 | 112.29 |
| Cash Conversion Cycle | -55.01 | -49.58 | 167.75 | 290.83 |
| Working Capital Days | -16.02 | -20.84 | 36.26 | 99.63 |
| ROCE % | 17.21% | 40.64% | 34.24% |